Ben Venue Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BEN VENUE, and what generic and branded alternatives to BEN VENUE drugs are available?
BEN VENUE has three approved drugs.
Drugs and US Patents for Ben Venue
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ben Venue | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | INJECTABLE;INJECTION | 076088-001 | Oct 15, 2002 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Ben Venue | MIDAZOLAM HYDROCHLORIDE | midazolam hydrochloride | INJECTABLE;INJECTION | 075455-001 | Jun 20, 2000 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
Ben Venue | FOLIC ACID | folic acid | INJECTABLE;INJECTION | 081066-001 | Dec 29, 1993 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.